Current role
General Counsel
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Axsome Therapeutics, Inc. (AXSM)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Axsome Therapeutics, Inc. (AXSM) | — | $505,000 | $3,245,542 |
| 2023 | Axsome Therapeutics, Inc. (AXSM) | — | $485,000 | $3,057,530 |
| 2022 | Axsome Therapeutics, Inc. (AXSM) | — | $450,000 | $2,484,699 |
| 2021 | Axsome Therapeutics, Inc. (AXSM) | — | $350,000 | $374,431 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.